The Straumann shareholders approved all the proposals put forward by the Board of Directors. 255 shareholders who together with the independent voting representative, represented 72.17% of the total share capital.

The shareholders approved the following:

• The Management Report, the Annual Financial Statements and the Consolidated Financial Statements for the 2022 business year.
• The Compensation Report for the 2022 business year, in a consultative vote.
• The appropriation of earnings and dividend payment for the 2022 business year: CHF 127 million for the dividend with a balance of approximately CHF 1.6  billion carried forward. The approved dividend corresponds to CHF 0.80 per share. The dividend will be paid net of 35% withholding tax as of 13 April 2023. The ex-dividend date is 11 April 2023.
  
• Discharge of the Board of Directors and the Executive Management for the 2022 business year.
• The fixed compensation of the Board of Directors collectively for the next term.
• The compensation of the Executive Management.
• The re-election of Gilbert Achermann as Member and Chairman of the Board, as well as Marco Gadola, Juan José Gonzalez, Petra Rumpf, Dr h.c. Thomas Straumann, Nadia Tarolli Schmidt and Regula Wallimann as Board Members – each for a term of one year. Dr Olivier Filliol was elected as a new Board Member for a term of one year. Dr Beat Lüthi decided not to stand for re-election. On behalf of the shareholders and the company, the Chair thanked him for his many contributions and wished him all the best for the future.
• The re-election of Nadia Tarolli Schmidt and Regula Wallimann and the election of Marco Gadola to the Human Resources & Compensation Committee for a term of one year.
• The re-election of Neovius AG in Basel as the independent voting representative for a term of one year.
• The re-election of Ernst & Young AG, Basel, as auditors for the 2023 business year. 
• Amendments of the Articles of Association.